Patents by Inventor Leila A. Telan

Leila A. Telan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted [(Phenylethanoyl)Amino]Benzamides
    Publication number: 20080171786
    Abstract: The invention relates to substituted [(phenylethanoyl)amino]benzamides and methods for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of inflammatory disorders such as, for example, cutaneous, respiratory tract and cardiovascular disorders such as, for example, arteriosclerosis and coronary heart disease.
    Type: Application
    Filed: November 17, 2005
    Publication date: July 17, 2008
    Inventors: Ulf Bruggemeier, Petros Gatsios, Mark Meininghaus, Leila Telan, Elisabeth Woltering, Martina Wuttke, Hartmut Beck, Nils Griebenow, Frank Sussmeier, Niels Svenstrup, Axel Kretschmer, Marcus Bauser, Johannes Kobberling, Wahed Moradi, Siegfried Zaiss, Claudia Hirth-Dietrich, Barbara Albrecht
  • N-biarylamides
    Patent number: 7354930
    Abstract: The invention relates to N-biarylamides useful for the prophylaxis and/or treatment of impairments of perception, concentration, learning and/or memory, and to processes for preparing them, and pharmaceutical compositions containing them.
    Type: Grant
    Filed: July 19, 2004
    Date of Patent: April 8, 2008
    Assignee: Bayer HealthCare AG
    Inventors: Timo Fleβner, Frank-Gerhard Böβ, Frank-Thorsten Hafner, Joachim Luithle, Christoph Methfessel, Leila Telan
  • 1,4-Diaryl-Dihydropyrimidin-2-Ones and Their Use as Human Neutrophil Elastase Inhibitors
    Publication number: 20080064704
    Abstract: The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
    Type: Application
    Filed: February 15, 2005
    Publication date: March 13, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Heike Gielen-Haertwig, Barbara Albrecht, Jorg Keldenich, Volkhart Li, Josef Pernerstorfer, Karl-Heinz Schlemmer, Leila Telan
  • Dihydropyridinone Derivatives
    Publication number: 20080045541
    Abstract: The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
    Type: Application
    Filed: February 5, 2005
    Publication date: February 21, 2008
    Applicant: Bayer-HealthCare AG
    Inventors: Heike Gielen-Haertwig, Barbara Albrecht, Marcus Bauser, Jorg Keldenich, Volkhart Li, Josef Pernerstorfer, Karl-Heinz Schlemmer, Leila Telan
  • Heterocyclic Derivatives
    Publication number: 20080021053
    Abstract: The invention relates to novel heterocyclic derivatives of the general formula (I), processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
    Type: Application
    Filed: February 15, 2005
    Publication date: January 24, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Heike Gielen-Haertwig, Barbara Albrecht, Jorg Keldenich, Volkhart Li, Josef Pernerstorfer, Karl-Heinz Schlemmer, Leila Telan
  • Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
    Publication number: 20070167406
    Abstract: The invention relates to novel dihydropyridine derivatives, of Formula (I) processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
    Type: Application
    Filed: August 18, 2003
    Publication date: July 19, 2007
    Inventors: Heike Gielen-Haertwig, Volkhart Min-Jian Li, Ulrich Rosentreter, Karl-Heinz Schiemmer, Swen Allerheiligen, Leila Telan, Lars Bärfacker, Jörg Keldenich, Mary Fitzgerald, Kevin Nash, Barbara Albrecht, Dirk Meurer
  • Dihydropyridinone derivatives
    Patent number: 7230017
    Abstract: The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: June 12, 2007
    Assignee: Bayer Healthcare AG
    Inventors: Heike Gielen-Haertwig, Volkhart Min-Jian Li, Ulrich Rosentreter, Karl-Heinz Schlemmer, Swen Allerheiligen, Leila Telan, Lars Bärfacker, Jörg Keldenich, Mary F. Fitzgerald, Kevin Nash, Barbara Albrecht, Dirk Meurer
  • N-biarylamides
    Publication number: 20070112023
    Abstract: The invention relates to N-biarylamides, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improvement in cognition, concentration power, learning power and/or memory.
    Type: Application
    Filed: July 19, 2004
    Publication date: May 17, 2007
    Inventors: Timo Flessner, Frank-Gerhard Boss, Frank-Thorsten Hafner, Joachim Luithle, Christoph Methfessel, Leila Telan
  • Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
    Publication number: 20060160801
    Abstract: The invention relates to novel heterocyclic derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases.
    Type: Application
    Filed: August 28, 2003
    Publication date: July 20, 2006
    Inventors: Heike Gielen-Haertwig, Volkhart Li, Ulrich Rosentreter, Karl-Heinz Schlemmer, Swen Allertheiligen, Leila Telan, Lars Barfacker, Jorg Keldenich, Mary Fitzgerald, Kevin Nash, Barbara Albrecht, Dirk Meurer
  • Heterocyclic derivatives
    Publication number: 20060111377
    Abstract: The invention relates to novel heterocyclic derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
    Type: Application
    Filed: August 28, 2003
    Publication date: May 25, 2006
    Applicant: Bayer Healthcare A G
    Inventors: Heike Gielen-Haertwig, Volkhart Li, Ulrich Rosentreter, Karl-Heinz Schlemer, Swen Sllerheiligen, Leila Telan, Lars Barfacker, Jorg Keldenich, Mary Fitzgerald, Kevin Nash, Barbara Albrecht, Dirk Meurer
  • Dihydropyridinone derivatives
    Publication number: 20060100207
    Abstract: The invention relates to novel dihydropyridinone derivatives, processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.
    Type: Application
    Filed: August 18, 2003
    Publication date: May 11, 2006
    Applicant: Bayer Healthcare AG
    Inventors: Heike Gielen-Haertwig, Volkhart Li, Ulrich Rosentreter, Karl-Heinz Schlemmer, Swen Allerheiligen, Leila Telan, Lars Barfacker, Jorg Keldenich, Mary Fitzgerald, Kevin Nash, Barbara Albrecht, Dirk Meurer
  • Enzyme-activated anti-tumor prodrug compounds
    Patent number: 6855689
    Abstract: Disclosed are enzyme-activated anti-tumor and anti-metastatic prodrug compounds. The specific enzymes are collagenase(IV) and elastase. Also disclosed are methods of making and using such compounds.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: February 15, 2005
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Raymond A. Firestone, Leila A. Telan
  • Tetrahydroquinoxalines acting as bradykinin antagonists
    Publication number: 20040235849
    Abstract: The invention relates to novel tetrahydroquinoxalines and processes for their preparation, their use for the treatment and/or the prophylaxis of diseases, in particular for the treatment and/or prophylaxis of states of pain.
    Type: Application
    Filed: June 14, 2004
    Publication date: November 25, 2004
    Inventors: Bettina Beyreuther, Michael Hahn, Christopher Kallus, Joachim Kruger, Heinrich Meier, Elke Reibmuller, Leila Telan, Reilinde Nopper, Mathias Kroll
  • FAP-activated anti-tumour compounds
    Patent number: 6613879
    Abstract: The invention relates to a prodrug that is capable of being converted into a drug by the catalytic action of human fibroblast activation protein (FAP&agr;), said prodrug having a cleavage site which is recognised by FAP&agr;, and said drug being cytotoxic or cytostatic under physiological conditions.
    Type: Grant
    Filed: April 21, 2000
    Date of Patent: September 2, 2003
    Assignees: Boehringer Ingelheim Pharma KG, Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Raymond A. Firestone, Wolfgang J. Rettig, Martin Lenter, Stefan Peters, Pilar Garin-Chesa, Juergen Mack, Dietmar Leipert, John E. Park, Leila A. Telan
  • Enzyme-activated anti-tumor prodrug compounds
    Publication number: 20020147138
    Abstract: Disclosed are enzyme-activated anti-tumor and anti-metastatic prodrug compounds. The specific enzymes are collagenase(IV) and elastase. Also disclosed are methods of making and using such compounds.
    Type: Application
    Filed: May 23, 2002
    Publication date: October 10, 2002
    Applicant: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Raymond A. Firestone, Leila A. Telan